Urachal adenocarcinoma: A clinician's guide for treatment

Seminars in Oncology

Volumn 39, Issue 5, 2012, Pages 619-624

  Siefker Radtke, Arlene ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BEVACIZUMAB; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; CISPLATIN; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; METHOTREXATE; MITOMYCIN; OXALIPLATIN; PACLITAXEL; PANITUMUMAB; VINBLASTINE;

ARTICLE; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CARCINOMATOUS PERITONITIS; COMPUTER ASSISTED TOMOGRAPHY; CYSTECTOMY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LONG TERM CARE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURGICAL ANATOMY; SURGICAL APPROACH; TREATMENT RESPONSE; UMBILICUS; URACHAL ADENOCARCINOMA; UROTHELIUM;

ADENOCARCINOMA; COMBINED MODALITY THERAPY; HUMANS; RECURRENCE; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84866985822     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2012.08.011     Document Type: Article

References (23)

1. C.A. Sheldon, R.V. Clayman, R. Gonzalez, R.D. Williams, E.E. Fraley Malignant urachal lesions J Urol 131 1984 1 8
2. A.O. Siefker-Radtke, J. Gee, Y. Shen Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience J Urol 169 2003 1295 1298
3. D.R. Henly, G.M. Farrow, H. Zincke Urachal cancer: role of conservative surgery Urology 42 1993 635 639
4. J.L. Wright, M.P. Porter, C.I. Li, P.H. Lange, D.W. Lin Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder Cancer 107 2006 721 728
5. G.E. Schubert, M.B. Pavkovic, B.A. Bethke-Bedurftig Tubular urachal remnants in adult bladders J Urol 127 1982 40 42
6. D.E. Johnson, G.B. Hodge, F.W. Abdul-Karim, A.G. Ayala Urachal carcinoma Urology 26 1985 218 221
7. R.A. Ashley, B.A. Inman, T.J. Sebo Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy Cancer 107 2006 712 720
8. J. Wheeler, W.T. Hill Adenocarcinoma involving the urinary bladder Cancer 7 1954 119 1954
9. F.K. Mostofi, R.V. Thomson, A.L.J. Dean Mucous adenocarcinoma of the urinary bladder Cancer 8 1955 741 758
10. A. Siefker-Radtke Urachal carcinoma: surgical and chemotherapeutic options Expert Rev Anticancer Ther 6 2006 1715 1721
11. A.O. Siefker-Radtke, B.A. Czerniak, C.P. Dinney, R.E. Millikan Uncommon cancers of the bladder D. Raghavan, D. Johnson, N. Meropol, P. Moots, P. Rose, Textbook of uncommon cancer 3rd ed. 2006 Wiley Philadelphia 18 26
12. M. Takeuchi, K. Matsuzaki, S. Yoshida, H. Nishitani, H. Uehara Imaging findings of urachal mucinous cystadenocarcinoma associated with pseudomyxoma peritonei Acta Radiologica 45 2004 348 350
13. J.R. Molina, J.F. Quevedo, A.F. Furth, R.L. Richardson, H. Zincke, P.A. Burch Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases Cancer 110 2007 2434 2440
14. H.W. Herr, B.H. Bochner, D. Sharp, G. Dalbagni, V.E. Reuter Urachal carcinoma: contemporary surgical outcomes J Urol 178 2007 74 78
15. J.H. Pinthus, R. Haddad, J. Trachtenberg Population based survival data on urachal tumors J. Urol 175 2006 2042 2047
16. V. Lane Prognosis in carcinoma of the urachus Eur Urol 2 1976 282 283
17. T. Kakizoe Adenocarcinoma of urachus Report of 7 cases and review of literature Urology 21 1983 360 366
18. C.J. Logothetis, M.L. Samuels, S. Ogden Chemotherapy for adenocarcinomas of bladder and urachal origin: 5-fluorouracil, doxorubicin, and mitomycin-C Urology 26 1985 252 255
19. A.O. Siefker-Radtke, R.E. Millikan, S.M. Tu Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer J Clin Oncol 20 2002 1361 1367
20. M.D. Galsky, A. Iasonos, S. Mironov Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract Urology 69 2007 255 259
21. N.M. Tannir, P.F. Thall, C.S. Ng A phase II trial of gemcitabine plus capecitabine for metastatic renal cell cancer previously treated with immunotherapy and targeted agents J Urology 180 2008 867 872
22. Y. Kojima, Y. Yamada, H. Kamisawa, S. Sasaki, Y. Hayashi, K. Kohri Complete response of a recurrent advanced urachal carcinoma treated by S-1/cisplatin combination chemotherapy Int J Urol 13 2006 1123 1125
23. H. Kume, K. Tomita, S. Takahashi, K. Fukutani Irinotecan as a new agent for urachal cancer Urol Int 76 2006 281 282